PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Phased formulations of ethinylestradiol
Presentation Product Chemical substance Chapter Items dispensed
Logynon tablets
0703010P0BBAAAA
Logynon Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders 4,287
TriRegol tablets
0703010P0BIAAAA
TriRegol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders 1,523
Logynon ED tablets
0703010P0BBABAE
Logynon Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders 796
Synphase tablets (Pfizer)
0703010P0BEAAAF
Synphase Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders 136
Generic Logynon tablets
0703010P0AAAAAA
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders 1
Binovum tablets
0703010P0BDAAAB
Binovum Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Generic Binovum tablets
0703010P0AAABAB
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Generic Logynon ED tablets
0703010P0AAAEAE
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Generic Synphase tablets
0703010P0AAAFAF
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Generic Tri-Minulet tablets
0703010P0AAADAD
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Generic Trinovum tablets
0703010P0AAACAC
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Synphase tablets (Imported (Canada))
0703010P0BEABAF
Synphase Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Synphase tablets (Imported (Germany))
0703010P0BEACAF
Synphase Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Tri-Minulet tablets
0703010P0BGAAAD
Tri-Minulet Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Triadene tablets
0703010P0BHAAAD
Triadene Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Trinordiol tablets
0703010P0BCAAAA
Trinordiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Trinovum tablets
0703010P0BFAAAC
Trinovum Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.